April 2024
Publication: News
Source / Author: The National News
Professor Stefan Neubauer, a professor of cardiovascular medicine at the University of Oxford and the Chief Translational Officer of Caristo Diagnostics, discusses with The National News how the utilisation of AI in CaRi-Heart technology has revolutionised cardiovascular risk assessment in patients. Read his interview here.
Read more
May 2024
Author: Caristo Diagnostics
Caristo Diagnostics, a leading cardiac disease diagnostics company, has been named by Newsweek as one of World’s Best Digital Health…
Read more
May 2024
Author: Cardiovascular Business
Prof Nehal Mehta, our esteemed Scientific Advisory Board member and Director of Inflammatory Risk and Preventive Cardiology at the Hospital…
© 2024 Caristo Diagnostics
This website and its contents are copyright 2018 - 2024 Caristo Diagnostics Ltd. All rights reserved. No content may be copied, used or distributed without the express written permission of Caristo Diagnostics Ltd. All copyright, trade-marks, design and other intellectual property rights (registered and unregistered) in and on this website are owned by or exclusively licensed to Caristo Diagnostics Ltd.
This Caristo website uses cookies. A cookie is a small text file which is stored on the browser of the device (laptop or smartphone) which you use to access our website. The cookie contains letter and numbers which uniquely identify your device and may contain other information such as your past preferences or actions. You can read more about cookies at http://www.aboutcookies.org. We do not require your consent to use cookies which are strictly necessary for our website to function securely, but will collect your consent for all other types of cookies.
Caristo does not use the following types of cookies. If in future we add any to our website we will explain their purpose to you and request your consent:
- Advertising/Marketing Cookies
- Personalisation Cookies
Caristo uses these kinds of cookies:
